Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.
about
Interaction of the Oncofetal Thomsen-Friedenreich Antigen with Galectins in Cancer Progression and MetastasisThe role of galectin-4 in physiology and diseases.Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigensHuman galectin-2 interacts with carbohydrates and peptides non-classically: new insight from X-ray crystallography and hemagglutinationGalectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisPromoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma.Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinomaGalectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cellsGalectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer CellsGalectin-4, a novel predictor for lymph node metastasis in lung adenocarcinomaGalectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinomaCirculating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal CancerChemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium.The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patientsCirculating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis.Proteomics of cancer cell lines resistant to microtubule-stabilizing agents.The sweet and bitter sides of galectins in melanoma progression.Galectin-8: a matricellular lectin with key roles in angiogenesis.Galectins in cancer: carcinogenesis, diagnosis and therapy.Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.MUC1 (CD227): a multi-tasked molecule.Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis.Promoter SNPs rs116896264 and rs73933062 form a distinct haplotype and are associated with galectin-4 overexpression in colorectal cancer.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells.Role of galectins in lung cancer.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.Seasonal and flight-related variation of galectin expression in heart, liver and flight muscles of yellow-rumped warblers (Setophaga coronata).Altered galectin-1 serum levels in patients diagnosed with high-grade glioma.Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells.Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma.Tumor cells interact with red blood cells via galectin-4 - a short report.
P2860
Q26749378-3FAD2B28-2591-4664-A106-9B9F5DFDD69CQ26750700-6FB768C3-C6DA-4C9D-A8F8-FE4D816F625DQ27701016-1A716C44-AD94-4883-ACF1-CC8C2ECA5186Q27727738-AC5037AD-EA69-49D7-B6EA-4ADD3B43A5EEQ28081459-30862FB5-A966-4511-A4B6-6266794E4D40Q28388257-E5EA0357-B41F-459B-BC84-D3C64BCDD9B8Q33618857-C1F77BC9-5779-4234-A046-C0BCC76F67ADQ34221829-3D75B247-7D1A-4360-AC89-6BCD6AFB7150Q34258192-CBB3BF5F-3649-4EF4-87B3-76EF8461B4E2Q34639786-337A7899-01C8-491E-A815-2C2DF5F1E646Q34793403-805EE759-BC68-4A6F-AB67-BFF4FE0F33DCQ35067654-1DF69AAE-D9BB-4700-A215-9654DD7C723BQ35713459-33DBAF17-35F7-4BDF-B0B7-18817D85A244Q36095578-ACE3436F-1474-4929-9A93-0397DF7701B8Q36414261-783117F2-C5B6-4358-A34A-90F2F03DCF96Q36746178-5C5C6701-5731-460F-BCAF-921C6DA51161Q37246080-3F3C5A89-EBF7-42C8-BB9B-F45E4404EFA5Q37559103-4C930EC8-954A-4D61-A806-9E1B1691AB72Q37625745-2CE36BF0-BE47-4D8C-9BC6-163DDB622444Q38016538-96EAEED8-69F8-48EF-B52F-C8F94430EE6AQ38221079-5A73B9C7-C242-4666-AF43-31AC713E0A11Q38269048-A4B1E1C7-0DB1-4B69-9E9E-DBC3113A1290Q38561302-730BCE27-1327-4C0E-A382-15EFC61A01A9Q38570769-9BE410BE-4BFA-42B1-8F78-E53F2039405EQ38737142-8CF5938C-8247-4693-A932-0C0A4FD18221Q38887855-0BCE863D-77E0-46C3-8C89-7E1FABDEDEE5Q38951257-2372A9E7-2297-4AC6-8C56-77E120FD5C26Q40197366-5C9B85F0-0002-456C-B124-E922C4D4CE87Q41334598-3C076BB4-59C2-462A-A117-1B4A24D57C30Q42706133-4FAC5501-2A39-4249-B973-0EAB856CA5F5Q43244358-16DC43B7-A199-4A64-A667-1722A30DE4D7Q47108427-D3BD147F-858E-4004-9550-DB15971C5149Q47329197-58312B0A-05AB-4053-8397-351A388C440BQ47664454-9E231008-2093-47E9-8423-56058D7CABADQ48270428-FB489EB3-13DD-487E-9A58-928F7D222D70Q50593924-DA98C390-42C9-414B-A690-A7330ADA79A5Q50860307-9C069480-A889-4C57-BED6-656F7E22CB6FQ51079321-7B1F21F9-306C-49AD-ABDB-4E45B98B0D56Q51823617-D68ED36D-547D-4556-AEDA-20F29801A255Q52948746-64972884-9F12-4B56-A214-F2F50E5C6F0C
P2860
Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@en
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@nl
type
label
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@en
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@nl
prefLabel
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@en
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@nl
P2093
P1476
Serum galectin-2, -4, and -8 a ...... to blood vascular endothelium.
@en
P2093
Hannah Barrow
Johannes W Pedersen
Jonathan M Rhodes
Lu-Gang Yu
Qicheng Zhao
P304
P356
10.1158/1078-0432.CCR-11-1462
P407
P577
2011-09-20T00:00:00Z